Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.14 - $0.25 $4,111 - $7,342
-29,370 Reduced 73.98%
10,329 $1,000
Q1 2023

May 15, 2023

SELL
$0.23 - $0.41 $5,192 - $9,256
-22,578 Reduced 36.25%
39,699 $10,000
Q4 2022

Feb 14, 2023

BUY
$0.22 - $14.5 $13,700 - $903,016
62,277 New
62,277 $19,000

About HELIUS MEDICAL TECHNOLOGIES, INC.


  • Ticker HSDT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 28,197,200
  • Market Cap $13.8M
  • Description
  • Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gai...
More about HSDT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.